252 related articles for article (PubMed ID: 32807169)
1. Follicular dendritic cell sarcoma of the uterine cervix: a case report.
Nakamura T; Yoshihara M; Tamauchi S; Kajiyama H; Kikkawa F
BMC Womens Health; 2020 Aug; 20(1):182. PubMed ID: 32807169
[TBL] [Abstract][Full Text] [Related]
2. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
Nasu K; Takai N; Narahara H
J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
[TBL] [Abstract][Full Text] [Related]
3. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal follicular dendritic cell sarcoma in a young woman: Diagnosis and treatment challenges.
Bouriga R; Abdessaied N; Hochlef M; Mallat N; Mahjoub M; Sriha B; Ahmed SB
Curr Probl Cancer; 2018; 42(3):350-357. PubMed ID: 29395417
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
6. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
[TBL] [Abstract][Full Text] [Related]
7. Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor.
Matsuura Y; Murakami N; Nagashio E; Toki N; Kashimura M
J Obstet Gynaecol Res; 2001 Jun; 27(3):129-32. PubMed ID: 11561828
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
Tangjitgamol S; Manusirivithaya S; Choomchuay N; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P
J Obstet Gynaecol Res; 2007 Apr; 33(2):218-24. PubMed ID: 17441901
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
[TBL] [Abstract][Full Text] [Related]
10. Serous Carcinoma of the Uterine Cervix, an Extremely Rare Aggressive Entity: A Literature Review.
Jonska-Gmyrek J; Zolciak-Siwinska A; Gmyrek L; Michalski W; Poniatowska G; Fuksiewicz M; Wiechno P; Kucharz J; Kowalska M; Kotowicz B
Gynecol Obstet Invest; 2018; 83(3):220-226. PubMed ID: 29393245
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J
Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169
[TBL] [Abstract][Full Text] [Related]
14. [Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
Tan YT; Zhang X; Lin ZQ; Chen Q; Wang LJ; Zhang BZ
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):120-3. PubMed ID: 18683751
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease.
Wu YL; Wu F; Xu CP; Chen GL; Zhang Y; Chen W; Yan XC; Duan GJ
Diagn Pathol; 2019 Jan; 14(1):5. PubMed ID: 30646936
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature.
Su Z; Liu G; Liu J; Fang T; Zeng Y; Zhang H; Yang S; Wang Y; Zhang J; Wei J; Li Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):11983-94. PubMed ID: 26722384
[TBL] [Abstract][Full Text] [Related]
17. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
18. [Follicular dendritic cell sarcoma: a clinicopathologic analysis of ten cases].
Yin WH; Yu GY; Ma Y; Rao HL; Lin SX; Shao CK; Liang Q; Guo N; Chen GQ; Zhou W; Zhao T; Zhu MG
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):522-7. PubMed ID: 21055030
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
